Aet Laboratories Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 8.18 Cr
as on 23-06-2024
- Company Age 21 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.24 Cr
as on 23-06-2024
- Revenue 44.30%
(FY 2022)
- Profit 74.85%
(FY 2022)
- Ebitda 68.83%
(FY 2022)
- Net Worth 43.69%
(FY 2022)
- Total Assets 42.63%
(FY 2022)
About Aet Laboratories
The Corporate was formerly known as Medikon Galenicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 8.18 Cr.
The company currently has active open charges totaling ₹2.42 M.
Dr Stark, Dieter Schoenfeld, Kristian Ruepp, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC041756
- Company No.
041756
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2003
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aet Laboratories Private Limited offer?
Aet Laboratories Private Limited offers a wide range of products and services, including Software Development & IT Consultant, Software Development Services, Branding & Advertising Agencies, Advertising Service.
Who are the key members and board of directors at Aet Laboratories?
Board Members(5)
Financial Performance and Corporate Structure Insights of Aet Laboratories.
Aet Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.3% increase. The company also saw a substantial improvement in profitability, with a 74.85% increase in profit. The company's net worth Soared by an impressive increase of 43.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aet Laboratories?
In 2022, Aet Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aet Clinical Services Private Limited
Active
9 years 8 months Oliver Schrader and Swapnil Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 11 Nov 2022 | ₹1.00 M | Open |
Hdfc Bank Limited Creation Date: 26 Apr 2021 | ₹0.71 M | Open |
Hdfc Bank Limited Creation Date: 16 Apr 2021 | ₹0.71 M | Open |
How Many Employees Work at Aet Laboratories?
Aet Laboratories has a workforce of 304 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aet Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aet Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
